MedImmune Ventures

Summary

MedImmune Ventures is the famous VC, which was founded in 1987. The main department of described VC is located in the Gaithersburg. The fund was located in North America if to be more exact in United States. MedImmune Ventures seemed to be an CVC arrangement as part of the organization.

For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular fund investment industries, there are Health Care, Pharmaceutical. The fund has specific favorite in a number of founders of portfolio startups. When startup sums 3 or 4 of the founder, the probability for it to get the investment is little. Among the most popular portfolio startups of the fund, we may highlight VLST Corporation, Iomai Corporation, Sequoia Pharmaceuticals. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.

The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the MedImmune Ventures, startups are often financed by Advanced Technology Ventures, Oxford Bioscience Partners, SV Health Investors. The meaningful sponsors for the fund in investment in the same round are Advanced Technology Ventures, SV Health Investors, Oxford Bioscience Partners. In the next rounds fund is usually obtained by SV Health Investors, Pitango Venture Capital, Clarus Ventures.

Opposing the other organizations, this MedImmune Ventures works on 0 percentage points less the average amount of lead investments. Deals in the range of 10 - 50 millions dollars are the general things for fund. The high activity for fund was in 2009. Speaking about the real fund results, this VC is 4 percentage points less often commits exit comparing to other organizations. The typical startup value when the investment from MedImmune Ventures is 5-10 millions dollars. The top amount of exits for fund were in 2015. The fund is constantly included in 2-6 deals per year.